Clinical Trial Update: Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating symptomatic and functional outcomes of atomoxetine in children with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 4 | Status: COMPLETED